Quantinuum (NASDAQ:QNT) Raised to Strong-Buy at Evercore

Quantinuum (NASDAQ:QNTGet Free Report) was upgraded by research analysts at Evercore to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.

QNT has been the topic of several other research reports. Morgan Stanley started coverage on Quantinuum in a research report on Monday. They set an “equal weight” rating and a $78.00 price objective on the stock. Jefferies Financial Group started coverage on shares of Quantinuum in a report on Monday. They issued a “buy” rating and a $90.00 price objective for the company. UBS Group began coverage on shares of Quantinuum in a report on Monday. They set a “buy” rating and a $93.00 target price on the stock. Mizuho began coverage on shares of Quantinuum in a research report on Monday. They issued an “outperform” rating and a $90.00 price target for the company. Finally, Wall Street Zen upgraded Quantinuum to a “hold” rating in a research note on Saturday, June 20th. Three analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $98.75.

Get Our Latest Research Report on Quantinuum

Quantinuum Trading Down 3.6%

NASDAQ:QNT opened at $72.84 on Monday. Quantinuum has a 1-year low of $50.10 and a 1-year high of $81.48.

Insider Activity

In other news, insider Kevin Scott Dehoff purchased 15,000 shares of Quantinuum stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average price of $60.00 per share, for a total transaction of $900,000.00. Following the transaction, the insider owned 126,460 shares of the company’s stock, valued at approximately $7,587,600. The trade was a 13.46% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Kenneth D. Denman acquired 14,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average cost of $60.00 per share, for a total transaction of $840,000.00. Following the completion of the purchase, the director directly owned 19,833 shares of the company’s stock, valued at $1,189,980. The trade was a 240.01% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders acquired 411,032 shares of company stock valued at $24,661,920.

Quantinuum News Summary

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Multiple firms initiated coverage on Quantinuum with bullish calls, including JPMorgan, Rosenblatt, Craig Hallum, Bank of America, Needham, Mizuho, and Sanford C. Bernstein, with several price targets implying meaningful upside. Analyst coverage and price targets
  • Positive Sentiment: Rosenblatt was the most bullish, assigning a buy rating and a $155 target, signaling strong confidence in Quantinuum’s long-term growth potential. Rosenblatt coverage
  • Positive Sentiment: Congressional trading activity also drew attention after Rep. Cleo Fields reportedly made a new quantum-related bet, adding to investor interest in the sector. Congressman Who Buys Magnificent Seven Stocks With Size Made New Quantum Bet
  • Neutral Sentiment: Morgan Stanley initiated coverage with an equal weight rating and a $78 target, which is more cautious than peers but still above the recent trading level. Morgan Stanley coverage
  • Negative Sentiment: Despite the bullish analyst wave, the stock has been falling, suggesting investors may be taking profits or reacting to valuation concerns after the sharp run-up in interest around quantum computing. Quantinuum stock falls: why is Wall Street bullish on the stock?

Quantinuum Company Profile

(Get Free Report)

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.

Further Reading

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.